Similar articles

• Stroke prevention: measuring and closing the anticoagulation gap.

  [No authors listed] [No authors listed] Am J Manag Care. 2004 Dec;10(14 Suppl):S447-50. Am J Manag Care. 2004. PMID: 15696908 Review. No abstract available.
• [Reasons for underuse of oral anticoagulation in atrial fibrillation-associated stroke: prospective study of German stroke patients].

  Reicke B, Masuhr F, Weih M. Reicke B, et al. Fortschr Neurol Psychiatr. 2008 Jul;76(7):391-5. doi: 10.1055/s-2008-1038216. Fortschr Neurol Psychiatr. 2008. PMID: 18604772 German.
• Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment.

  Audebert HJ, Schenk B, Tietz V, Schenkel J, Heuschmann PU. Audebert HJ, et al. Cerebrovasc Dis. 2008;26(2):171-7. doi: 10.1159/000145324. Epub 2008 Jul 15. Cerebrovasc Dis. 2008. PMID: 18628615 Clinical Trial.
• Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment.

  Poli D, Antonucci E, Grifoni E, Abbate R, Gensini GF, Prisco D. Poli D, et al. Thromb Haemost. 2009 May;101(5):938-42. Thromb Haemost. 2009. PMID: 19404548
• Anticoagulation: stroke prevention in patients with atrial fibrillation.

  Waldo AL. Waldo AL. Cardiol Clin. 2009 Feb;27(1):125-35, ix. doi: 10.1016/j.ccl.2008.09.002. Cardiol Clin. 2009. PMID: 19111769 Review.